Sbi Securities Co., Ltd. Novo Cure LTD Transaction History
Sbi Securities Co., Ltd.
- $3.48 Trillion
- Q2 2025
A detailed history of Sbi Securities Co., Ltd. transactions in Novo Cure LTD stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 1,313 shares of NVCR stock, worth $14,889. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,313
Previous 1,229
6.83%
Holding current value
$14,889
Previous $21.9 Million
6.71%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding NVCR
# of Institutions
271Shares Held
73.5MCall Options Held
971KPut Options Held
118K-
Black Rock Inc. New York, NY12.1MShares$138 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.8MShares$122 Million0.0% of portfolio
-
Capital World Investors Los Angeles, CA6.38MShares$72.4 Million0.02% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT5.52MShares$62.6 Million8.14% of portfolio
-
State Street Corp Boston, MA2.59MShares$29.4 Million0.0% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.19B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...